Laboratorios Farmaceuticos Rovi S.A. Logo

Laboratorios Farmaceuticos Rovi S.A.

Integrated pharma firm developing prescription drugs and offering contract manufacturing services.

ROVI | MC

Overview

Corporate Details

ISIN(s):
ES0157261019
LEI:
95980020140005936480
Country:
Spain
Address:
JULIAN CAMARILLO 35, 28037 Madrid
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorios Farmaceuticos Rovi S.A. is a specialized and fully integrated pharmaceutical company founded in 1946. The company's core activities encompass the research, development, manufacturing, and commercialization of a range of pharmaceutical products, with a focus on prescription and hospital-grade medicines. In addition to its proprietary product pipeline, ROVI also provides contract manufacturing services to third parties, offering a comprehensive suite of solutions including production, testing, packaging, and storage.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 00:00
AGM Information
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
Spanish 152.8 KB
2025-05-08 07:56
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-05-08 07:54
Regulatory Filings
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
Spanish 171.1 KB
2025-05-08 07:39
Investor Presentation
La Compañía hace pública la presentación relativa a los resultados financieros …
Spanish 957.7 KB
2025-05-08 07:35
Earnings Release
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
Spanish 631.0 KB
2025-05-08 00:00
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-04-04 10:27
Transaction in Own Shares
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
Portuguese 219.9 KB
2025-03-25 10:03
Investor Presentation
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
Spanish 2.3 MB
2025-03-25 08:00
Investor Presentation
La Sociedad hace pública la presentación relativa a la actualización de su estr…
Spanish 2.3 MB
2025-02-25 07:54
Report Publication Announcement
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
Spanish 85.6 KB
2025-02-25 07:49
Investor Presentation
La Sociedad hace pública la presentación de los resultados financieros del ejer…
Spanish 1.4 MB
2025-02-25 07:47
Earnings Release
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
Spanish 672.9 KB
2025-02-25 07:15
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.7 KB
2025-02-25 07:10
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 3.5 MB
2025-02-25 00:00
Annual / Quarterly Financial Statement
English 615.4 KB

Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorios Farmaceuticos Rovi S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.